Last reviewed · How we verify
NCT04647747: SHYCOV
Silent Hypoxia and Awake Proning in COVID-19 Patients
NA trial testing Self measurement with pulse oximeter in Covid19 in 40 participants. Completed in 30 March 2021.
30 March 2021
Quick facts
| Lead sponsor | Ostfold Hospital Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 30 November 2020 |
| Primary completion | 30 March 2021 |
| Estimated completion | 30 March 2021 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Self measurement with pulse oximeter
Conditions studied
Sponsor
Ostfold Hospital Trust
Who can join
Adults 18 to 80, any sex, with Covid19 or Hypoxemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Investigators want to examine patients infected with SARS-CoV-2 for the phenomenon "Silent Hypoxia", which is clinically significant hypoxia without corresponding degree of dyspnea. The patient population is infected individuals without any serious symptoms and is at home. The participants will be equipped with a pulse oximeter and a PEF-measurement device. Four times daily the participants will register saturation, degree of dyspnea and PEF. If the participants experience desaturation or increasing dyspnea, physiotherapy is to be performed, and if that doesn't relieve symptoms or increase oxygen saturation, the hospital should be contacted for admission. The first part of this study is a feasibility study, and if found feasible, the investigators will expand the study to more participants.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients-a single-arm prospective trial.
Myklebust-Hansen HJ, Hasvik E, Solyga VM, Ghanima W. · · 2023 · PMID 38042811 · DOI 10.1186/s40814-023-01415-x -
The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients
Myklebust-Hansen HJ, Hasvik E, Ghanima W, Solyga V. · · 2023 · DOI 10.21203/rs.3.rs-2506837/v1
Verify or expand the search:
- PubMed search for NCT04647747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Ostfold Hospital Trust trials
Trials by the same sponsor.
- NCT07051915 — The Holistic Study · Phase 3 · not yet recruiting
- NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
- NCT06842446 — Systematic Machine Learning Algorithm for Rapid Thrombosis Detection · NA · recruiting
- NCT06568276 — The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures · NA · recruiting
- NCT05778916 — 5 Year Radiological and Clinical Results From Patients Operated for Hallux Valgus Deformity. · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04647747 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ostfold Hospital Trust
- Last refreshed: 18 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04647747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing